Crohn’s disease and ulcerative colitis, which are the most common types of inflammatory bowel disease (IBD), are more common ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D ...

Cancer cases in the under-50s are rising, and experts believe it may be linked to their gut health. Here’s how to fix it ...

Learn about colorectal cancer, its risk factors, symptoms, and the latest treatment options. Early detection through ...

Researchers recently looked at the most common initial red flags of colorectal cancer in people younger than 50 and published ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high clinical activity score (CAS) Thyroid Eye Disease (TED) ...

Fintel reports that on September 24, 2024, TD Cowen initiated coverage of Protagonist Therapeutics (NasdaqGM:PTGX) with a Buy ...

Fzata, Inc. is pleased to announce a five-year UG3/UH3 non-dilutive grant (UG3NS135350) of up to $7 million, plus in-kind ...

Breakdown of the mucus barrier, which separates the intestinal epithelium from the microbiota, is a hallmark of inflammatory ...

Georgiamune continues biotech innovation streak with first autoimmune disease-focused program based on novel biologyGAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a ...

Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...